[HTML][HTML] Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome …

J Tang, GT Lam, RD Brooks, M Miles, Z Useckaite… - Cancer Letters, 2024 - Elsevier
The highly heterogenous nature of colorectal cancer can significantly hinder its early and
accurate diagnosis, eventually contributing to high mortality rates. The adenoma-carcinoma …

[HTML][HTML] Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression

J Lazniewska, KL Li, IRD Johnson, A Sorvina… - Scientific reports, 2023 - nature.com
Prostate cancer (PCa) development and progression relies on the programming of glucose
and lipid metabolism, and this involves alterations in androgen receptor expression and …

[HTML][HTML] Insights into melanoma clinical practice: a perspective for future research

GT Lam, C Martini, T Brooks, S Prabhakaran… - Cancers, 2023 - mdpi.com
Simple Summary This study acknowledges the challenges in melanoma diagnosis and the
need for new technology that aids clinical decision making. Biomarkers that can accurately …

[HTML][HTML] Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread

A Sorvina, C Martini, S Prabhakaran, JM Logan… - Pathology, 2023 - Elsevier
The presence of intraductal carcinoma of the prostate (IDCP) correlates with late-stage
disease and poor outcomes for patients with prostatic adenocarcinoma, but the accurate and …

[HTML][HTML] Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer

C Martini, JM Logan, A Sorvina, S Prabhakaran… - Virchows Archiv, 2023 - Springer
High-grade prostatic intraepithelial neoplasia (HGPIN) is a well-characterised precursor
lesion in prostate cancer. The term atypical intraductal proliferations (AIP) describes lesions …

[HTML][HTML] In Advanced Prostate Cancer, a String of Modest Gains Are Changing Patient Care

J Kaltwasser - 2023 - targetedonc.com
In Advanced Prostate Cancer, a String of Modest Gains Are Changing Patient Care NEWS
All NewsFDA BriefsOncology IconsSpecial ReportsVoices from the Field CONFERENCES …

[引用][C] Novel prostate cancer biomarker test launches on US market

H Clarke